Page last updated: 2024-09-05

sb 203580 and ristocetin

sb 203580 has been researched along with ristocetin in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(ristocetin)
Trials
(ristocetin)
Recent Studies (post-2010) (ristocetin)
3,48941,1371,51523125

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balduini, C; Canobbio, I; Reineri, S; Sinigaglia, F; Torti, M1

Other Studies

1 other study(ies) available for sb 203580 and ristocetin

ArticleYear
A role for p38 MAP kinase in platelet activation by von Willebrand factor.
    Thrombosis and haemostasis, 2004, Volume: 91, Issue:1

    Topics: Antibodies, Monoclonal; Antigens, CD; Arachidonic Acid; Blood Platelets; Cyclooxygenase Inhibitors; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Enzyme Precursors; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phospholipases A; Phospholipases A2; Phosphorylation; Platelet Activation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Protein-Tyrosine Kinases; Pyridines; Receptors, IgG; Ristocetin; Signal Transduction; Syk Kinase; Thromboxane A2; Time Factors; von Willebrand Factor

2004